PDCD1 and cancer: Further analysis of the neural-signal-related ligand-receptor networks suggested that APP may synergistically promote cancer proliferation and migration by interacting with CD74, CAV1, and LRP1 in the tumor core region (Figure 4D), which were reported to enhance the migration and invasive capabilities of tumor cells and induce anti-PD-1 resistance.33